Loading Events

« All Events

  • This event has passed.

13th Vaccine Congress

September 15 - September 18

Organizers from Elsevier’s journal Vaccine will host the 13th Vaccine Congress 15-18 September 2019 in Bangkok, Thailand.

The congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field.

Agenda topics of interest highlighted by the Global Biodefense staff include:

  • Insertion-responsive microneedles for rapid intradermal delivery of influenza vaccine
  • Immunogenicity of virus-like particle (VLP)-based coronavirus vaccines
  • A brief review of adversomics: understanding genetic drivers for adverse events after vaccination
  • Developing a novel, safe and effective platform for generating flavivirus vaccines
  • Novel adenoviral vector platform for developing a universal influenza vaccine
  • Chicken IFITM knockout technology for increased vaccine production
  • The role of the microbiome in host interactions and vaccine responses
  • Optimized recombinant Newcastle disease virus expressing the F protein of respiratory syncytial virus has improved antigen expression levels and immunogenicity
  • Identification of immunostimulatory domains of flagellin for better adjuvant design
  • Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
  • Development of bat stem cell lines by somatic reprogramming to study bat-derived
    highly pathogenic viruses
  • Vaccination with 1/6th standard dose of a split inactivated influenza vaccine using the Nanopatch™
    induces comparable immune responses to conventional full-dose intramuscular injection
  • Mucosal immunity in therapeutic and prophylactic vaccine trials
  • Translating the intestinal microbiome for oral vaccine performance
  • Neuraminidase-based influenza virus vaccines
  • Assessment of outer membrane vesicles derived from Escherichia coli Nissle 1917as a novel mucosal adjuvant in intranasal inactivated influenza vaccine
  • Enhancing Chikungunya Virus Immunity By Improved Vaccination
  • Pre-clinical protective efficacy of a VLP-based vaccine against Zika virus
  • Needle Adapters and Needle-free Injectors for Intradermal Administration of Fractional Dose of
    Inactivated Poliovirus Vaccine

Please visit the 13th Vaccine Congress website for more information and to register for the event.

Details

Start:
September 15
End:
September 18
Event Category:
Website:
http://bit.ly/13th-vaccine-congress

Organizer

Elsevier
Website:
http://www.elsevier.com/

Venue

Avani Riverside Hotel
257 Charoennakorn Road
Thonburi, Bangkok 10600 Thailand
Phone:
+66 2431 9100
Website:
https://www.avanihotels.com/en/riverside-bangkok